Brown, Lisle/Cummings’s Sanofi SNY Stock Holding History

Brown, Lisle/Cummings’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.32K	Sell	31 -24	-44%	-$1.07K	﹤0.01%	923
2026 Q1	$2.66K	Buy	55 +31	+129%	+$1.45K	﹤0.01%	769
2025 Q4	$1.18K	Hold	24	–	–	﹤0.01%	676
2025 Q3	$1.15K	Hold	24	–	–	﹤0.01%	690
2025 Q2	$1.17K	Hold	24	–	–	﹤0.01%	698
2025 Q1	$1.33K	Buy	+24	New	+$1.3K	﹤0.01%	685

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Brown, Lisle/Cummings's SNY Position: Q2 2026 in Review

Brown, Lisle/Cummings reduced its Sanofi (SNY) stake by 44% in Q2 2026, selling an estimated $1.07K and leaving 31 shares worth $1.32K. The position accounts for ﹤0.01% of the portfolio, ranked #923.

Brown, Lisle/Cummings first reported a position in SNY in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.66K in Q1 2026. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Brown, Lisle/Cummings held 31 shares of Sanofi worth $1.32K as of Q2 2026.
Brown, Lisle/Cummings sold 24 Sanofi shares in Q2 2026, an estimated $1.07K.
Sanofi made up ﹤0.01% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #923 holding.
Brown, Lisle/Cummings first reported a position in Sanofi in Q1 2025 and has held it in 6 quarters since.
Brown, Lisle/Cummings's Sanofi position peaked at $2.66K in Q1 2026.
716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.